autologous plasmablasts engineered to express α-L-iduronidase (IDUA) / Masonic Cancer Center, University of Minnesota, Immusoft - LARVOL DELTA

MT2018-18: Sleeping Beauty Transposon-Engineered Plasmablasts for Hurler Syndrome Post Allo HSCT (clinicaltrials.gov) - P1/2 | N=0 | Withdrawn | Sponsor: Masonic Cancer Center, University of Minnesota | N=36 ➔ 0 | Not yet recruiting ➔ Withdrawn

Enrollment change • Trial withdrawal • Bone Marrow Transplantation • Hurler Syndrome • Transplantation